Other languages CellaVision AB

Equities

CEVI

SE0000683484

Market Closed - Nasdaq Stockholm Other stock markets 11:29:48 2024-04-19 am EDT			5-day change	1st Jan Change
224.5 ^SEK	+2.05%		+1.35%	+5.90%

Feb. 07	Transcript : CellaVision AB, Q4 2023 Earnings Call, Feb 07, 2024
Feb. 07	CellaVision AB Proposes Dividend for the Year 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CellaVision AB Proposes Dividend for the Year 2023	Feb. 07
CellaVision AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 07
Cellavision, Sysmex Expand Hematology Partnership Deal	Feb. 06
CellaVision and Sysmex Corporation Sign Strategic Alliance Agreement	Feb. 06
Small Caps: Ein lukratives Einstiegsfenster zeichnet sich ab	Nov. 24
Kleine kapitalisaties: een instapmoment tekent zich af	Nov. 22
Small caps: Se asoma una ventana de entrada	Nov. 20
Small caps : Une fenêtre d'entrée se profile	Nov. 20
CellaVision AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-25
CellaVision AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-20
Cellavision AB Announces Executive Changes	23-05-05
Cellavision AB Approves Dividend, Payable on May 12, 2023	23-05-05
CellaVision AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-04
Revenio Group Oyj: pure player op een snelgroeiende markt	23-02-17
CellaVision AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-08
CellaVision AB Proposes Dividend for 2022, Payable on 12 May 2023	23-02-07
CellaVision AB Announces the Appointment of Emil Hjalmarsson as Chairman of the Nomination Committee	22-11-25
CellaVision AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-26
CellaVision® Launches a Complete Workflow Solution for Low-Volume Hematology Laboratories	22-07-27
CellaVision AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-07-20

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages CellaVision AB

Equities

CEVI

SE0000683484

Other languages

Filters